In particular, a CD44+/CD24−/low subpopulation was identified to have tumour-initiating properties in breast cancer [15], and its tumourigenic phenotype was demonstrated to be related to stem cell-like properties [16]. The gene discussed is CD44; the disease is breast carcinoma.